A third explanation for heterozygote advantage could be even the involvement of an additional factor [47, 48] or an interaction of the IRX3 promoter with the obesity-associated SNP region of FTO [18]. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.